9Grabiec AM, Krausz S, de Jager W, et al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis pa- tient synowial macrephages and tissue. J Immtmol, 2010, 184 (5) : 2718-2728.
10Duffy N, Walker P, Diamantea F, et al. Intravenous aminophyUine in patients admired to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled triM. Thorax,2005,60(9) :713-717.
3Nussbaumer-ochsner Y,Rabe KF.Systemic manifestations of COPD[J].Chest,2011,139(1):165-173.
4Barnes PJ,Celli BR.Systemic manifestations and comor-bidities of COPD[J].Eur Respir J,2009,33(5):1165-1185.
5Lin HH,Murray M,Cohen T,et al.Effects of smoking and solid-fuel use on COPD,lung cancer,and tuberculosis in China:a time-based,multiple risk factor,modelling study[J].Lancet,2008,372(9648):1473-1483.
6Barnes PJ.The cytokine network in asthma and chronic obstructive pulmonary disease[J].J Clin Invest,2008,118:3546-6556.
7Walter RE,Wilk JB,Larson MCP,et al.systemic inflammation and COPD:Framingham heart study[J].Chest,2008,133:19-25.
8Peacock JL,Anderson HR,Bremner SA,et al.Outdoor air pollution and respiratory health in patients w ith COPD[J].Thorax,2011,66(7):591-596.
9Sandelowsky H,Stallberg B,Nager A,et al.The prevalence of undiagnosed chronic obstructive pulmonary disease in a primary care population w ith respiratory tract in fections-a case finding study[J].BM C Fam Pract,2011,12:122.
10Hersh CP,Hokanson JE,Lynch DA,et al.Family history is a risk factor for COPD[J].Chest,2011,140(2):343-350.
